TherapeuticsMD® Announces Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
TherapeuticsMD (TXMD) Tops Q3 EPS by 2c, Revenues Beat
November 9, 2020 6:57 AM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $15.33 million.
Third Quarter 2020 Summary
Total net revenue increased 80% to $19.3 million for the third quarter of 2020 as compared... More
